These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7234465)

  • 1. Depression and cerebrospinal fluid citrate.
    Mellerup ET; Rafaelsen OJ
    Acta Psychiatr Scand; 1981 Jan; 63(1):57-60. PubMed ID: 7234465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disorders.
    Verbanck PM; Lotstra F; Gilles C; Linkowski P; Mendlewicz J; Vanderhaeghen JJ
    Life Sci; 1984 Jan; 34(1):67-72. PubMed ID: 6694511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients.
    Gerner RH; Yamada T
    Brain Res; 1982 Apr; 238(1):298-302. PubMed ID: 6123376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptides in the cerebrospinal fluid (CSF) in psychiatric disorders.
    Rafaelsen OJ; Gjerris A
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):533-8. PubMed ID: 3937176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls.
    Pitts AF; Samuelson SD; Meller WH; Bissette G; Nemeroff CB; Kathol RG
    Biol Psychiatry; 1995 Sep; 38(5):330-5. PubMed ID: 7495928
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebrospinal fluid vasopressin in neurological and psychiatric disorders.
    Sørensen PS; Gjerris A; Hammer M
    J Neurol Neurosurg Psychiatry; 1985 Jan; 48(1):50-7. PubMed ID: 3973621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression with versus without manic features in rapid-cycling bipolar disorder.
    Goldberg JF; Wankmuller MM; Sutherland KH
    J Nerv Ment Dis; 2004 Sep; 192(9):602-6. PubMed ID: 15348976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania.
    Singh V; Bowden CL; Mintz J
    Int Clin Psychopharmacol; 2013 Mar; 28(2):91-5. PubMed ID: 23238761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Li+ therapy and site of origin on cerebrospinal fluid beta-amyloid precursor protein derivatives.
    Clarke NA; Procter AW; Webster MT; Francis PT; Hodgkiss AD; Bowen DM
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):242S. PubMed ID: 7901097
    [No Abstract]   [Full Text] [Related]  

  • 10. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central neurochemical ultradian variability in depression.
    Salomon RM; Johnson BW; Schmidt DE
    Dis Markers; 2006; 22(1-2):65-72. PubMed ID: 16410652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls.
    Gjerris A; Widerlöv E; Werdelin L; Ekman R
    J Psychiatry Neurosci; 1992 Mar; 17(1):23-7. PubMed ID: 1349825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment-induced manic switch in the course of unipolar depression can predict bipolarity: cluster analysis based evidence.
    Dumlu K; Orhon Z; Özerdem A; Tural U; Ulaş H; Tunca Z
    J Affect Disord; 2011 Nov; 134(1-3):91-101. PubMed ID: 21742381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melancholic/endogenous depression and response to somatic treatment and placebo.
    Peselow ED; Sanfilipo MP; Difiglia C; Fieve RR
    Am J Psychiatry; 1992 Oct; 149(10):1324-34. PubMed ID: 1388334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive function after clinical remission in patients with melancholic and non-melancholic depression: a 6 month follow-up study.
    Roca M; Monzón S; Vives M; López-Navarro E; Garcia-Toro M; Vicens C; Garcia-Campayo J; Harrison J; Gili M
    J Affect Disord; 2015 Jan; 171():85-92. PubMed ID: 25299439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers.
    Naber D; Pickar D; Post RM; Van Kammen DP; Waters RN; Ballenger JC; Goodwin FK; Bunney WE
    Am J Psychiatry; 1981 Nov; 138(11):1457-62. PubMed ID: 6271019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP levels in cerebrospinal fluid in manic-melancholic patients.
    Geisler A; Bech P; Johannesen M; Rafaelsen OJ
    Neuropsychobiology; 1976; 2(4):211-20. PubMed ID: 189250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transition from the depressive stage to the manic stage during the treatment with antidepressive drugs].
    Koszewska I; Puzyński S
    Psychiatr Pol; 1991; 25(3-4):76-82. PubMed ID: 1821982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid vasopressin--changes in depression.
    Gjerris A; Hammer M; Vendsborg P; Christensen NJ; Rafaelsen OJ
    Br J Psychiatry; 1985 Dec; 147():696-701. PubMed ID: 3938307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of antidepressants on the cerebrospinal fluid homovanillic acid/5-hydroxyindoleacetic acid ratio.
    Risby ED; Hsiao JK; Sunderland T; Agren H; Rudorfer MV; Potter WZ
    Clin Pharmacol Ther; 1987 Nov; 42(5):547-54. PubMed ID: 2445515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.